Home Healthcare Biotechnology Computational Pathology Market

Computational Pathology Market Size, Share & Trends Analysis Report By Component (Software, Services), By Application (Disease Diagnosis, Drug Discovery & Development, Academic Research), By Technology (Machine Learning (ML), Natural Language Processing (NLP) Models, Computer Vision, Others), By End-use (Hospitals and Diagnostic Labs, Biotechnology and Pharmaceutical Companies, Academic and Research Institutes, Other) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: December 31, 2025 | Author: Debashree B | Format: | Report Code: SR7700DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Computational Pathology Market, By Component 2022-2034 (USD MILLION/ Units)
    1. Software
    2. Services
  2. Computational Pathology Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Disease Diagnosis
    2. Drug Discovery & Development
    3. Academic Research
  3. Computational Pathology Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Machine Learning (ML)
      1. Deep Learning
      2. Supervised
      3. Unsupervised
      4. Others
    2. Natural Language Processing (NLP) Models
    3. Computer Vision
    4. Others
  4. Computational Pathology Market, By End-use 2022-2034 (USD MILLION/ Units)
    1. Hospitals and Diagnostic Labs
    2. Biotechnology and Pharmaceutical Companies
    3. Academic and Research Institutes
    4. Other
  5. Regional Computational Pathology Market
    1. North America
      1. North America Computational Pathology Market By Component 2022-2034 (USD MILLION/ Units)
        1. Software
        2. Services
      2. North America Computational Pathology Market By Application 2022-2034 (USD MILLION/ Units)
        1. Disease Diagnosis
        2. Drug Discovery & Development
        3. Academic Research
      3. North America Computational Pathology Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        2. Natural Language Processing (NLP) Models
        3. Computer Vision
        4. Others
      4. North America Computational Pathology Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Diagnostic Labs
        2. Biotechnology and Pharmaceutical Companies
        3. Academic and Research Institutes
        4. Other
      5. U.S.
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      6. Canada
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
    2. Europe
      1. Europe Computational Pathology Market By Component 2022-2034 (USD MILLION/ Units)
        1. Software
        2. Services
      2. Europe Computational Pathology Market By Application 2022-2034 (USD MILLION/ Units)
        1. Disease Diagnosis
        2. Drug Discovery & Development
        3. Academic Research
      3. Europe Computational Pathology Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        2. Natural Language Processing (NLP) Models
        3. Computer Vision
        4. Others
      4. Europe Computational Pathology Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Diagnostic Labs
        2. Biotechnology and Pharmaceutical Companies
        3. Academic and Research Institutes
        4. Other
      5. U.K.
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      6. Germany
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      7. France
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      8. Spain
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      9. Italy
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      10. Russia
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      11. Nordic
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      12. Benelux
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      13. Rest of Europe
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
    3. APAC
      1. APAC Computational Pathology Market By Component 2022-2034 (USD MILLION/ Units)
        1. Software
        2. Services
      2. APAC Computational Pathology Market By Application 2022-2034 (USD MILLION/ Units)
        1. Disease Diagnosis
        2. Drug Discovery & Development
        3. Academic Research
      3. APAC Computational Pathology Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        2. Natural Language Processing (NLP) Models
        3. Computer Vision
        4. Others
      4. APAC Computational Pathology Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Diagnostic Labs
        2. Biotechnology and Pharmaceutical Companies
        3. Academic and Research Institutes
        4. Other
      5. China
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      6. Korea
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      7. Japan
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      8. India
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      9. Australia
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      10. Taiwan
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      11. South East Asia
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      12. Rest of Asia-Pacific
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
    4. Middle East and Africa
      1. Middle East and Africa Computational Pathology Market By Component 2022-2034 (USD MILLION/ Units)
        1. Software
        2. Services
      2. Middle East and Africa Computational Pathology Market By Application 2022-2034 (USD MILLION/ Units)
        1. Disease Diagnosis
        2. Drug Discovery & Development
        3. Academic Research
      3. Middle East and Africa Computational Pathology Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        2. Natural Language Processing (NLP) Models
        3. Computer Vision
        4. Others
      4. Middle East and Africa Computational Pathology Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Diagnostic Labs
        2. Biotechnology and Pharmaceutical Companies
        3. Academic and Research Institutes
        4. Other
      5. UAE
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      6. Turkey
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      7. Saudi Arabia
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      8. South Africa
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      9. Egypt
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      10. Nigeria
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      11. Rest of MEA
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
    5. LATAM
      1. LATAM Computational Pathology Market By Component 2022-2034 (USD MILLION/ Units)
        1. Software
        2. Services
      2. LATAM Computational Pathology Market By Application 2022-2034 (USD MILLION/ Units)
        1. Disease Diagnosis
        2. Drug Discovery & Development
        3. Academic Research
      3. LATAM Computational Pathology Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        2. Natural Language Processing (NLP) Models
        3. Computer Vision
        4. Others
      4. LATAM Computational Pathology Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Diagnostic Labs
        2. Biotechnology and Pharmaceutical Companies
        3. Academic and Research Institutes
        4. Other
      5. Brazil
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      6. Mexico
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      7. Argentina
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      8. Chile
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      9. Colombia
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
      10. Rest of LATAM
        1. Software
        2. Services
        3. Disease Diagnosis
        4. Drug Discovery & Development
        5. Academic Research
        6. Machine Learning (ML)
          1. Deep Learning
          2. Supervised
          3. Unsupervised
          4. Others
        7. Natural Language Processing (NLP) Models
        8. Computer Vision
        9. Others
        10. Hospitals and Diagnostic Labs
        11. Biotechnology and Pharmaceutical Companies
        12. Academic and Research Institutes
        13. Other
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.